The Mosaic: Heart muscle (Monkey)/Skeletal muscle (Monkey) IIFT test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin classes IgG against heart muscle and skeletal muscle in human serum or plasma for the diagnosis of Myasthenia gravis.
Tthe Mosaic: Heart muscle (Monkey)/Skeletal muscle (Monkey) IIFT test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin classes IgG against heart muscle and skeletal muscle in human serum or plasma for the diagnosis of Myasthenia gravis.
The Heart muscle (monkey) IIFT test kit is designed for the qualitatively or quantitatively determination of human antibodies in human serum or plasmafor the diagnosis of Myasthenia gravis.
The IIFT: Liver Mosaic 1 test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgG in human serum or plasma for the diagnosis of autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), pernicious anaemia, myasthenia gravis and rheumatic diseases.
The CIBD Profile 7 IIFT test kit provides qualitative or semiquantitative determination of human antibodies of immunoglobulin classes IgA and IgG in human serum or plasmafor the diagnosis of chronic inflammatory bowel diseases (Crohn’s disease, ulcerative colitis).
The Heart muscle (monkey) IIFT test kit is designed for the qualitatively or quantitatively determination of human antibodies in human serum or plasmafor the diagnosis of Myasthenia gravis.
The IIFT Mosaic: HEp-2/Liver (Monkey) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class against cell nuclei in human serum or plasma for the diagnosis of many autoimmune diseases, particularly of the rheumatic form.
The Heart muscle (monkey) IIFT test kit is designed for the qualitatively or quantitatively determination of human antibodies in human serum or plasmafor the diagnosis of Myasthenia gravis.
The Anti-Chlamydia pneumoniae IIFT (IgA) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgA against Chlamydia pneumoniae in human serum or plasmafor the diagnosis of respiratory diseases (e.g. bronchitis, trachitis and pneumonia).
The Anti-Chlamydia pneumoniae IIFT (IgG) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgG against Chlamydia pneumoniae in human serum or plasmafor the diagnosis of respiratory diseases (e.g. bronchitis, trachitis and pneumonia).
The Anti-Chlamydia pneumoniae IIFT (IgM) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgM against Chlamydia pneumoniae in human serum or plasmafor the diagnosis of respiratory diseases (e.g. bronchitis, trachitis and pneumonia).
The Anti-Mycoplasma pneumoniae IIFT (IgA) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgA against Mycoplasma pneumoniae in human serum or plasma for the diagnosis of diseases of the upper and lower respiratory tract (rhinitis, pharyngitis, otitis media, bronchitis, pneumonia).
The Anti-Mycoplasma pneumoniae IIFT (IgG) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgG against Mycoplasma pneumoniae in human serum or plasma for the diagnosis of diseases of the upper and lower respiratory tract (rhinitis, pharyngitis, otitis media, bronchitis, pneumonia).
The Anti-Mycoplasma pneumoniae IIFT (IgM) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgM against Mycoplasma pneumoniae in human serum or plasma for the diagnosis of diseases of the upper and lower respiratory tract (rhinitis, pharyngitis, otitis media, bronchitis, pneumonia).
The Anti-Mycoplasma pneumoniae IIFT (IgA) test kit is designed for the qualitative or semiquantitative determination of human antibodies of immunoglobulin class IgA against Mycoplasma pneumoniae in human serum or plasma for the diagnosis of diseases of the upper and lower respiratory tract (rhinitis, pharyngitis, otitis media, bronchitis, pneumonia).